| Financial Year |
March 31 2023 |
| Monetary Funds |
2,128,653,953.41 |
| Held-for-trading Financial Assets |
5,349,066.21 |
| Notes Receivable |
1,446,337.31 |
| Accounts Receivable |
2,455,772,847.80 |
| Advances to Suppliers |
460,486,448.53 |
| Other Receivables |
111,139,657.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,318,121,193.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
232,566,178.86 |
| Total Current Assets |
10,823,942,521.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
60,607,730.89 |
| Long-term Equity Investment |
226,649,395.88 |
| Investment Properties |
-- |
| Fixed Assetes |
3,885,822,922.38 |
| Under-construction Projects |
988,467,076.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
346,422,698.90 |
| R&D expenses |
-- |
| Goodwill |
155,350,694.82 |
| Long-Term Deferred and Prepaid Expenses |
94,921,364.63 |
| Deferred Income Tax Assets |
189,956,275.45 |
| Other Non-Current Assets |
117,380,742.12 |
| Sub-Total of Non-Current Assets |
6,226,040,907.89 |
| Total Assets |
17,049,983,429.55 |
| Short-Term Loans |
2,941,337,809.37 |
| Trading Financial liabilities |
2,682,343.55 |
| Notes Payable |
2,210,860,504.13 |
| Accounts Payable |
2,222,783,992.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,438,642.30 |
| Taxes Payable |
25,950,796.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,387,579.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
848,935,484.78 |
| Other Current Liabilities |
129,578,692.97 |
| Sub-Total of Current Liabilities |
9,154,941,997.94 |
| Long-term Loans |
1,378,335,963.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
640,740,275.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,524,098.47 |
| Other Non-Current Liabilities |
403,000,000.00 |
| Sub-Total of Non-Current Liabilities |
2,708,035,125.49 |
| Total Liabilities |
11,862,977,123.43 |
| Paid-In Capital(Or Share Stock) |
864,870,893.00 |
| Capital Surplus |
3,924,191,925.34 |
| Surplus Reserve |
158,929,677.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
317,910,146.67 |
| Minority Stockholder's Interest |
-87,231,535.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,274,237,841.75 |
| Owner's Equity（Stockholder's Equity） |
5,187,006,306.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,049,983,429.55 |
